Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Key Features

Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions.
An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries.

Table of Contents

Contributors

Special reviews

Cumulative indexes of special reviews, Annuals 11–32

1 Index of drugs

2 Index of adverse reactions

Table of Essays, Annuals 1–32

Mechanistic and clinical descriptions of adverse drug reactions

1 EIDOS

2 DoTS

How to use this book

The scope of the Side Effects of Drugs Annuals

Period covered

Selection of material

Classification of drugs

Names of drugs and chemicals

System of tagging references

Indexes

Abbreviations

Side Effects Of Drugs Essay

Three generations

Renewed concern

Profiling the risk

A fourth generation?

The defenders

The view today

Conclusions

Chapter 1: Central nervous system stimulants and drugs that suppress appetite

Amphetamines [SED-15, 180; SEDA-30, 1; SEDA-31, 1; SEDA-32, 1]

Methylxanthines

Drugs that suppress appetite [SEDA-30, 7; SEDA-31, 9; SEDA-32, 16]

Drugs used in Alzheimer’s disease [SEDA-30, 8; SEDA-31, 10; SEDA-32, 19]

Chapter 2: Antidepressant drugs

General

Monoamine oxidase inhibitors [SED-15, 2371; SEDA-32, 32]

Selective serotonin re-uptake inhibitors (SSRIs) [SED-15, 3109; SEDA-30, 16; SEDA-31, 18; SEDA-32, 33]

Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

Other antidepressants

Chapter 3: Lithium

Chapter 4: Drugs of abuse

Cannabinoids [SED-15, 614; SEDA-30, 31; SEDA-31, 33; SEDA-32, 55]

Cocaine [SED-15, 848; SEDA-30, 31; SEDA-31, 37; SEDA-32, 58]

Opioid analgesics

Chapter 5: Hypnosedatives and anxiolytics

Azaspirones [SEDA-28, 52; SEDA-32, 75]

Benzodiazepines [SED-15, 429; SEDA-30, 49; SEDA-31, 57; SEDA-32, 75]

Benzodiazepine-like drugs

Benzodiazepine antagonists

Other hypnosedatives

Chapter 6: Antipsychotic drugs

Details

No. of pages:
1160
Language:
English
Copyright:
© 2011
Published:
Imprint:
Elsevier
Print ISBN:
9780444537416
Electronic ISBN:
9780444537423

About the editor

Jeffrey Aronson

Affiliations and Expertise

Reader in Clinical Pharmacology